Advances in Microfluidics for Pharmaceutical Applications

Access to essential medicine is a challenge in both developed and developing countries. The current global pandemic (COVID-19) has put a spotlight on, among others, the need to develop advanced technologies to reduce both the cost and the time for new drug development. Microfluidic technologies, although they are still limited by their production scalability and cost, are expected to play an important part in the future manufacturing of nanomedicine and administration of therapeutic products and diagnostics. Microfluidics meet the demand of high-quality and meticulously regulated medical products. Currently, researchers are focused on the development of cost-effective, high-impact technologies that will fill the missing link between excellent product development and efficient commercialization of novel therapeutics. This Special Issue aims to introduce the most representative and promising approaches of microfluidic technology on the areas of micro/nanofabrication, novel drug development, cell and drug encapsulation, drug screening, 3D disease models, and organ-on-chips.

We invite colleagues to submit a contribution either in the form of original research article or review.

Dr. Maryam Parhizkar
Dr. Dimitrios Tsaoulidis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.